Chemistry:5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole

From HandWiki
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole
Dichlororibofuranosylbenzimidazole.svg
Names
IUPAC name
5,6-Dichloro-1-(β-D-ribofuranosyl)-1H-1,3-benzimidazole
Systematic IUPAC name
(2R,3R,4S,5R)-2-(5,6-Dichloro-1H-1,3-benzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Other names
DRB, Dichlororibofuranosylbenzimidazole
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
DrugBank
UNII
Properties
C12H12Cl2N2O4
Molar mass 319.14 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a chemical compound that inhibits transcription elongation by RNA Polymerase II. Sensitivity to DRB is dependent on DRB sensitivity inducing factor (DSIF), negative elongation factor (NELF), and positive transcription elongation factor b (P-TEFb). DRB is a nucleoside analog and also inhibits some protein kinases.[1]

References

  1. Yamaguchi, Y.; Takagi, T.; Wada, T.; Yano, K.; Furuya, A.; Sugimoto, S.; Hasegawa, J.; Handa, H. (1999). "NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation.". Cell 97 (1): 41–51. doi:10.1016/S0092-8674(00)80713-8. PMID 10199401.